Gene-Editing Transfection Chemicals Market 2026 reaching $1.56 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Gene-Editing Transfection Chemicals Market Between 2026 And 2030?

The gene-editing transfection chemicals market has demonstrated strong expansion over recent years. Projections indicate it will increase from $1.07 billion in 2025 to $1.16 billion in 2026, at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historic period is attributable to factors such as the limited availability of high-efficiency transfection chemicals, a reliance on traditional delivery methods, growing academic and research institute activities, increasing investment in biotechnology research, and the early adoption of gene-editing tools.

The gene-editing transfection chemicals market is projected to experience robust expansion over the coming years. This market is anticipated to reach $1.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. The upward trend during the forecast period is driven by factors such as the advancement of lipid, polymer, and peptide-based chemicals, a growing need for accurate gene-editing applications, an increase in pharmaceutical and biotechnology research and development activities, the incorporation of automated transfection platforms, and a rise in regulatory clearances and established protocols. Key trends anticipated during this period encompass the increasing uptake of lipid-based transfection chemicals, broader utilization of polymer and peptide-based delivery systems, the expansion of both non-viral and viral delivery mechanisms, a wider application of gene-editing in drug discovery and disease modeling, and a concerted effort to enhance transfection efficiency and cell viability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25770&type=smp

What Drivers Are Influencing The Gene-Editing Transfection Chemicals Market?

The gene-editing transfection chemicals market is expected to grow, driven by the accelerated pace of gene therapy research. Gene therapy is a technique aimed at treating or preventing diseases by directly altering or correcting faulty genes within an individual’s cells. Breakthroughs in gene-editing technologies, such as CRISPR, which enable scientists to precisely target and modify genes responsible for genetic disorders, are fueling this acceleration in gene therapy research. Gene-editing transfection chemicals are crucial tools in gene therapy research and development, as they facilitate the efficient delivery of genetic material, including CRISPR-Cas9 components, mRNA, and plasmid DNA, into human cells. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, an increase from five approvals in 2022. Therefore, the intensified research in gene therapy is propelling the expansion of the gene-editing transfection chemicals market.

Which Market Segments Are Examined In The Gene-Editing Transfection Chemicals Market Study?

The gene-editing transfection chemicals market covered in this report is segmented –

1) By Chemical Type: Lipid-Based, Polymer-Based, Peptide-Based, Other Chemical Types

2) By Delivery Mechanism: Non-Viral, Viral

3) By Application: Biomedical Research, Drug Discovery, Disease Modeling, Agricultural Biotechnology, Vaccine Development, Other Applications

4) By End-User: Academic And Research Institutes, Biotechnology Companies, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Lipid-Based: Cationic Lipids, Neutral Lipids, Ionizable Lipids

2) By Polymer-Based: Polyethyleneimine (PEI), Poly(L-Lysine) (PLL), Dendrimers

3) By Peptide-Based: Cell-Penetrating Peptides (CPPs), Amphipathic Peptides, Targeting Peptides

4) By Other Chemical Types: Inorganic Nanoparticles, Hybrid Nanoparticles

Which Trends Are Influencing The Gene-Editing Transfection Chemicals Market?

Leading companies in the gene-editing transfection chemicals sector are prioritizing the introduction of innovative solutions, such as lipid nanoparticle (LNP) starter kits, to streamline the workflows for gene therapy and mRNA delivery. LNP starter kits are described as ready-to-use formulations or toolkits containing pre-optimized lipid components and protocols specifically designed to facilitate the development and testing of LNP-based delivery systems. For example, in February 2024, the Switzerland-based pharmaceutical company CordenPharma unveiled Lipid NanoParticle (LNP) Starter Kits. These kits are intended to assist researchers and developers in formulating and optimizing mRNA-based therapeutics, including vaccines and gene therapies. The kits incorporate four crucial lipids—ionizable lipids, helper lipids, sterols, and PEGylated lipids—which are obtained from commercial-scale, high-purity materials. This sourcing ensures consistent quality across batches and minimizes the risk of losing valuable payloads during the development process. CordenPharma’s goal, by providing a reliable and scalable lipid platform, is to accelerate the development of gene editing and mRNA therapies while simultaneously safeguarding high-value genetic payloads.

Who Are The Primary Competitors In The Gene-Editing Transfection Chemicals Market?

Major companies operating in the gene-editing transfection chemicals market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Takara Bio Inc., Mirus Bio LLC, OZ Biosciences SAS, Genlantis Inc., Polyplus-Transfection SA, Altogen Biosystems LLC, SignaGen Laboratories.

Read the full gene-editing transfection chemicals market report here:

https://www.thebusinessresearchcompany.com/report/gene-editing-transfection-chemicals-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Gene-Editing Transfection Chemicals Market?

North America was the largest region in the gene-editing transfection chemicals market in 2025. The regions covered in the gene-editing transfection chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene-Editing Transfection Chemicals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25770&type=smp

Browse Through More Reports Similar to the Global Gene-Editing Transfection Chemicals Market 2026, By The Business Research Company

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Genome Editing Or Genome Engineering Market Report 2026

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795